• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    XORTX Therapeutics Inc. - Common Shares (NQ:XRTX)

    1.770 +0.360 (+25.55%)
    Delayed Quote Updated: 1:19 PM EDT, Oct 12, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about XORTX Therapeutics Inc. - Common Shares

    News headline image
    Gout Treatments Need A Better Option: XORTX Therapeutics Is Betting XORLO Is It, Targets New Drug Application With FDA Next Year
    By Meg Flippin, Benzinga 
    Via NewMediaWire
    XORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical Trial
    Via Get News
    Topics Intellectual Property
    XORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical Trial
    New York, NY, March 19, 2024 – (Plato Data) -- In the realm of pharmaceutical innovation, XORTX Therapeutics Inc. (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), stands out for its... 
    Via TheNewswire.com
    Topics Intellectual Property
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.